Yu-Fen Chang

CEO and founder
LumiSTAR Biotechnology Inc.

​​​​​

Dr. Chang worked on projects involving the development of a variety of luminescent and fluorescent protein-based indicators during her PhD, which could be used for cellular dynamics measurements and real-time in vivo tracking. In 2011, she was awarded the Japanese Society for the Promotion of Science (JSPS) fellowship to incorporate these indicators into the development of advanced imaging technology for measuring cellular function. Her research results were published in several high-impact journals. Subsequently, she received a research grant from BHF (2013-2016) to support her research at John Radcliffe Hospital at Oxford University, where she integrated the developed technologies into iPSC applications for drug screening and precision medicine. In 2016, she founded LumiSTAR Biotechnology and led the company in the development of high-throughput screening platforms for drug discovery and iPSC-associated cell therapy.
 

Speech title & Synopsis

Transforming drug discovery: Leverage the power of LumiRDTTM with advanced human iPSC-derived 3D models and high-throughput/content screening

.